IQVIA reports that global use of medicine has increased at a 3% compound annual growth rate since 2014, slowing from a 4% rate from 2009–2014.
Glenmark and Hikma will commercialize a fixed-dose combination nasal spray for seasonal allergic rhinitis.
The Remunity system to treat pulmonary arterial hypertension is expected to be available by July for specialty pharmacies.
Walgreens has earned the first enterprise-wide URAC Specialty Pharmacy accreditation for its network of more than 300 community specialty pharmacies.
Diplomat and OptumRx's combination will expand the innovative specialty pharmacy and infusion solutions that OptumRx can offer.
Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment
Diplomat is retaining a portion of the Envoy Health Management operations that specialize in digital therapeutics and pharmaceutical services.
Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.
Following the retirement of Chris Luthin, David Skomo has been named COO of Diplomat's pharmacy benefit manager CastiaRx.
Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA.
AmerisourceBergen has been chosen by Karyopharm to introduce a new treatment for patients with relapsed or refractory multiple myeloma.
Amber Pharmacy will dispense Celgene's Inrebic, a treatment for patients with certain types of myelofibrosis.
PDX is releasing Envoy Dx to meet the needs and custom data feeds required in specialty pharmacy reporting.
AllianceRx Walgreens Prime has added new specialty drugs for patients with rare conditions, such as MS and non-Hodgkin's lymphoma.
